Metraipolis › archive › dc_ca44ecbddcbc

Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and… — Europe PMC PMID:42187603

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42187603
DOI
10.3390/curroncol33050286
License (as archived)
solo-consultazione
Archived
2026-11-02T10:04:08.887Z
SHA-256 of the archived text
af877aaff8bb1d3576001eb4e981c978614e08ffdb7538bff0260e4219c60d6c
Stable URL of this page
https://metraipolis.com/documento/dc_ca44ecbddcbc

How to cite

Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and… — Europe PMC PMID:42187603 — Europe PMC (en), https://europepmc.org/article/MED/42187603 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca44ecbddcbc (Metraipolis archive dc_ca44ecbddcbc, sha256 af877aaff8bb1d3576001eb4e981c978614e08ffdb7538bff0260e4219c60d6c)
BibTeX
@misc{dcca44ecbddcbc,
  title = {Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and… — Europe PMC PMID:42187603},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42187603},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca44ecbddcbc; sha256 af877aaff8bb1d3576001eb4e981c978614e08ffdb7538bff0260e4219c60d6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42187603. Agents can read the archived copy with the MCP tool read_document.